drugset / Trial / NCT00604708
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
RandomizedParallel-groupSingle-blindPrevention
Summary
The objective is to demonstrate the non-inferiority of the Japanese Encephalitis vaccine IC51 compared to JE-VAX in healthy subjects aged \> or = 18 years
Timeline
- Start
- 2005-09
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IC51 | Vaccine | 6 ug | Intramuscular |
| Comparator | JE-VAX® | Vaccine | 1 ml | Subcutaneous |